Cargando…

Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials: A Systematic Review and Meta-analysis

IMPORTANCE: Sex, age, and Eastern Cooperative Oncology Group (ECOG) performance status (PS) may affect immune response. However, the association of these factors with the survival benefit of cancer immunotherapy with immune checkpoint inhibitors (ICIs) remains unclear. OBJECTIVE: To assess the poten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fang, Markovic, Svetomir N., Molina, Julian R., Halfdanarson, Thorvardur R., Pagliaro, Lance C., Chintakuntlawar, Ashish V., Li, Rutian, Wei, Jia, Wang, Lifeng, Liu, Baorui, Nowakowski, Grzegorz S., Wang, Michael L., Wang, Yucai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414387/ https://www.ncbi.nlm.nih.gov/pubmed/32766800 http://dx.doi.org/10.1001/jamanetworkopen.2020.12534

Ejemplares similares

Pilot Study Characterizing the Hematology-Oncology Fellow Job Search Process: Tools Used and Identification of Potential New Resources
por: Marshall, Ariela L., et al.
Publicado: (2021)

Mayo Clinic Cancer Center Experience of Metastatic Extramammary Paget Disease 1998-2012
por: Padrnos, Leslie, et al.
Publicado: (2016)

Development and validation of a nomogram for predicting survival in patients with malignant myofibroblastic tumor
por: Wang, Xiaolu, et al.
Publicado: (2023)

Advances in systemic therapy for advanced pancreatobiliary malignancies
por: Halfdanarson, Thorvardur R, et al.
Publicado: (2013)

The detection and significance of EGFR and BRAF in cell-free DNA of peripheral blood in NSCLC
por: Yang, Yang, et al.
Publicado: (2017)

Primary neuroendocrine carcinoma of the brain
por: Reed, Clay T, et al.
Publicado: (2019)

Comparative Analysis of Predictive Biomarkers for PD-1/PD-L1 Inhibitors in Cancers: Developments and Challenges
por: Yang, Fang, et al.
Publicado: (2021)

Clinically Meaningful Use of Blood Tumor Markers in Oncology
por: Holdenrieder, Stefan, et al.
Publicado: (2016)

Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies
por: Diamantopoulos, Leonidas N., et al.
Publicado: (2023)

Targeted Alpha-Particle Therapy: A Review of Current Trials
por: Jang, Albert, et al.
Publicado: (2023)

Detection of PD-L1 Expression and Its Clinical Significance in Circulating Tumor Cells from Patients with Non-Small-Cell Lung Cancer
por: Cheng, Yuxin, et al.
Publicado: (2020)

Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy
por: Galli, Filippo, et al.
Publicado: (2020)

Constrictive bronchiolitis in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
por: Samhouri, Bilal F., et al.
Publicado: (2020)

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma
por: Wang, Yucai, et al.
Publicado: (2018)

Detection and monitoring of driver mutations by next‐generation sequencing in squamous cell lung cancer patient and possible predictive biomarker of third generation EGFR‐tyrosine kinase inhibitors
por: Shen, Xiaoyan, et al.
Publicado: (2017)

Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer
por: Zhang, Lianru, et al.
Publicado: (2017)

Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals
por: Azam, Faisal, et al.
Publicado: (2019)

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis
por: Yang, Fang, et al.
Publicado: (2022)

Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells
por: Wang, Qin, et al.
Publicado: (2021)

Incidence and Survival Outcomes in Patients with Lung Neuroendocrine Neoplasms in the United States
por: Shah, Shrunjal, et al.
Publicado: (2021)

Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells
por: Wang, Qin, et al.
Publicado: (2020)

Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights
por: Starr, Jason S, et al.
Publicado: (2020)

Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth
por: Wu, Puyuan, et al.
Publicado: (2018)

A case of bilateral synchronous double primary lung cancer secondary to bladder cancer: From the next‐generation sequencing prospect
por: Qiu, Yuling, et al.
Publicado: (2023)

Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy
por: Halfdanarson, Thorvardur R., et al.
Publicado: (2023)

Salvage Therapy With Multikinase Inhibitors and Immunotherapy in Advanced Adrenal Cortical Carcinoma
por: Miller, Kevin C, et al.
Publicado: (2020)

Management of Diarrhea in Patients With Carcinoid Syndrome
por: Naraev, Boris G., et al.
Publicado: (2019)

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas
por: Smaglo, Brandon G., et al.
Publicado: (2015)

Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy
por: Zhu, Junmeng, et al.
Publicado: (2022)

The Quality of Online Information for an Uncommon Malignancy—Neuroendocrine Tumours (NETs)
por: Sohail, Safa, et al.
Publicado: (2021)

N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma
por: Halfdanarson, Thorvardur R, et al.
Publicado: (2022)

Dominant effects of Δ40p53 on p53 function and melanoma cell fate
por: Takahashi, Rie, et al.
Publicado: (2013)

Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group
por: Yoon, Harry H, et al.
Publicado: (2011)

Immunotherapies and Combination Strategies for Immuno-Oncology
por: Barbari, Cody, et al.
Publicado: (2020)

Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group
por: Fountzilas, Elena, et al.
Publicado: (2021)

Variation in geographic access to chemotherapy by definitions of providers and service locations: a population-based observational study
por: Schroeder, Mary C., et al.
Publicado: (2016)

Advances in the Use of Immunotherapy in Oncology
por: Olszanski, Anthony J., et al.
Publicado: (2017)

Immunotherapy – The New Era of Oncology
por: Kansy, Benjamin, et al.
Publicado: (2018)

Viral Capsid Is a Pathogen-Associated Molecular Pattern in Adenovirus Keratitis
por: Chintakuntlawar, Ashish V., et al.
Publicado: (2010)

Systemic therapy for recurrent or metastatic salivary gland malignancies
por: Chintakuntlawar, Ashish V., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b7k92ori1m4l78bl3v7jfeqq5d